We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Warning Letter to Patheon's Puerto Rico Unit
FDA Issues Warning Letter to Patheon's Puerto Rico Unit
October 3, 2005
Canadian drugmaker Patheon’s $350 million acquisition of Puerto Rico-based contract manufacturer Mova Pharmaceutical, announced late last year, could soon get a lot more expensive.